Zobrazeno 1 - 10
of 134
pro vyhledávání: '"Justin A, Green"'
Autor:
Sasha V. Siegel, Hidayat Trimarsanto, Roberto Amato, Kathryn Murie, Aimee R. Taylor, Edwin Sutanto, Mariana Kleinecke, Georgia Whitton, James A. Watson, Mallika Imwong, Ashenafi Assefa, Awab Ghulam Rahim, Hoang Chau Nguyen, Tinh Hien Tran, Justin A. Green, Gavin C. K. W. Koh, Nicholas J. White, Nicholas Day, Dominic P. Kwiatkowski, Julian C. Rayner, Ric N. Price, Sarah Auburn
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-16 (2024)
Abstract Challenges in classifying recurrent Plasmodium vivax infections constrain surveillance of antimalarial efficacy and transmission. Recurrent infections may arise from activation of dormant liver stages (relapse), blood-stage treatment failure
Externí odkaz:
https://doaj.org/article/9bc856d4342e4495a19575b3200d2f4d
Autor:
Ann Marie Stanley, Anastasia A. Aksyuk, Deidre Wilkins, Justin A. Green, Dongmei Lan, Kathryn Shoemaker, Hong-Van Tieu, Magdalena E. Sobieszczyk, Ann R. Falsey, Elizabeth J. Kelly
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundImmunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now widespread; however, the degree of cross-immunity between SARS-CoV-2 and endemic, seasonal human coronaviruses (HCoVs) remains unclear.MethodsSARS-CoV-2 and HCo
Externí odkaz:
https://doaj.org/article/c554ac5745cd4cd3be363647f832750a
Autor:
Cindy Duysburgh, Lisa Miclotte, Justin B. Green, Kevin T. Watts, Maria I. Sardi, Anirikh Chakrabarti, Ehsan Khafipour, Massimo Marzorati
Publikováno v:
Frontiers in Microbiology, Vol 15 (2024)
The yeast-based postbiotic EpiCor is a well-studied formulation, consisting of a complex mixture of bioactive molecules. In clinical studies, EpiCor postbiotic has been shown to reduce intestinal symptoms in a constipated population and support mucos
Externí odkaz:
https://doaj.org/article/cfb85771312b45e3a17f534874a4f2ce
Autor:
James A Watson, Robert J Commons, Joel Tarning, Julie A Simpson, Alejandro Llanos Cuentas, Marcus VG Lacerda, Justin A Green, Gavin CKW Koh, Cindy S Chu, François H Nosten, Richard N Price, Nicholas PJ Day, Nicholas J White
Publikováno v:
eLife, Vol 13 (2024)
In our recent paper on the clinical pharmacology of tafenoquine (Watson et al., 2022), we used all available individual patient pharmacometric data from the tafenoquine pre-registration clinical efficacy trials to characterise the determinants of ant
Externí odkaz:
https://doaj.org/article/a448849101ae42ba942170feabc3d8bf
Autor:
Hidayat Trimarsanto, Roberto Amato, Richard D. Pearson, Edwin Sutanto, Rintis Noviyanti, Leily Trianty, Jutta Marfurt, Zuleima Pava, Diego F. Echeverry, Tatiana M. Lopera-Mesa, Lidia M. Montenegro, Alberto Tobón-Castaño, Matthew J. Grigg, Bridget Barber, Timothy William, Nicholas M. Anstey, Sisay Getachew, Beyene Petros, Abraham Aseffa, Ashenafi Assefa, Awab G. Rahim, Nguyen H. Chau, Tran T. Hien, Mohammad S. Alam, Wasif A. Khan, Benedikt Ley, Kamala Thriemer, Sonam Wangchuck, Yaghoob Hamedi, Ishag Adam, Yaobao Liu, Qi Gao, Kanlaya Sriprawat, Marcelo U. Ferreira, Moses Laman, Alyssa Barry, Ivo Mueller, Marcus V. G. Lacerda, Alejandro Llanos-Cuentas, Srivicha Krudsood, Chanthap Lon, Rezika Mohammed, Daniel Yilma, Dhelio B. Pereira, Fe E. J. Espino, Cindy S. Chu, Iván D. Vélez, Chayadol Namaik-larp, Maria F. Villegas, Justin A. Green, Gavin Koh, Julian C. Rayner, Eleanor Drury, Sónia Gonçalves, Victoria Simpson, Olivo Miotto, Alistair Miles, Nicholas J. White, Francois Nosten, Dominic P. Kwiatkowski, Ric N. Price, Sarah Auburn
Publikováno v:
Communications Biology, Vol 5, Iss 1, Pp 1-10 (2022)
An online, amendable classifier for detecting malaria parasite country of origin from genomic data is developed using a machine learning approach.
Externí odkaz:
https://doaj.org/article/595d6999c2294de5a765b7b051ac5f17
Autor:
Jill Maaske, Stephanie Sproule, Ann R. Falsey, Magdalena E. Sobieszczyk, Anne F. Luetkemeyer, Grant C. Paulsen, Sharon A. Riddler, Merlin L. Robb, Charlotte-Paige Rolle, Beverly E. Sha, Tina Tong, Bahar Ahani, Anastasia A. Aksyuk, Himanshu Bansal, Timothy Egan, Brett Jepson, Marcelino Padilla, Nirmeshkumar Patel, Kathryn Shoemaker, Ann Marie Stanley, Phillip A. Swanson, Deidre Wilkins, Tonya Villafana, Justin A. Green, Elizabeth J. Kelly
Publikováno v:
Frontiers in Immunology, Vol 13 (2023)
BackgroundBreakthrough severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in coronavirus disease 2019 (COVID-19) vaccinees typically produces milder disease than infection in unvaccinated individuals.MethodsTo explore disease atte
Externí odkaz:
https://doaj.org/article/a7f99999dfa54de681877a3fca396db9
Autor:
James A Watson, Robert J Commons, Joel Tarning, Julie A Simpson, Alejandro Llanos Cuentas, Marcus VG Lacerda, Justin A Green, Gavin CKW Koh, Cindy S Chu, François H Nosten, Richard N Price, Nicholas PJ Day, Nicholas J White
Publikováno v:
eLife, Vol 11 (2022)
Tafenoquine is a newly licensed antimalarial drug for the radical cure of Plasmodium vivax malaria. The mechanism of action and optimal dosing are uncertain. We pooled individual data from 1102 patients and 72 healthy volunteers studied in the pre-re
Externí odkaz:
https://doaj.org/article/f5567952f4604510b3632a25a317789f
Autor:
Meera Madhavan, Adam J. Ritchie, Jeremy Aboagye, Daniel Jenkin, Samuel Provstgaad-Morys, Iona Tarbet, Danielle Woods, Sophie Davies, Megan Baker, Abigail Platt, Amy Flaxman, Holly Smith, Sandra Belij-Rammerstorfer, Deidre Wilkins, Elizabeth J. Kelly, Tonya Villafana, Justin A. Green, Ian Poulton, Teresa Lambe, Adrian V.S. Hill, Katie J. Ewer, Alexander D. Douglas
Publikováno v:
EBioMedicine, Vol 85, Iss , Pp 104298- (2022)
Summary: Background: Intranasal vaccination may induce protective local and systemic immune responses against respiratory pathogens. A number of intranasal SARS-CoV-2 vaccine candidates have achieved protection in pre-clinical challenge models, inclu
Externí odkaz:
https://doaj.org/article/c0218306af9949dca4663ba77a6bcb87
Autor:
Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck Jr., Hong-Van Tieu, Kenneth H. Mayer, Lawrence Corey, Kathleen M. Neuzil, Tina Tong, Margaret Brewinski Isaacs, Holly Janes, Himanshu Bansal, Lindsay M. Edwards, Justin A. Green, Elizabeth J. Kelly, Kathryn Shoemaker, Therese Takas, Tom White, Prakash Bhuyan, Tonya Villafana, and Ian Hirsch, on behalf of the AstraZeneca AZD1222 Clinical Study Group
Publikováno v:
The Journal of Clinical Investigation, Vol 132, Iss 18 (2022)
Background We report updated safety, efficacy, and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) from an ongoing phase 3 trial.Methods Adults at increased risk of SARS-CoV-2 infection were randomized (2:1), stratified by age, to receive 2 doses of AZD1
Externí odkaz:
https://doaj.org/article/0223bfbe518d427787c488021708dfaa
Autor:
Swathi Balaji, Walker D. Short, Benjamin W. Padon, Jorge A. Belgodere, Sarah E. Jimenez, Naresh T. Deoli, Anna C. Guidry, Justin C. Green, Tanuj J. Prajapati, Fayiz Farouk, Aditya Kaul, Dongwan Son, Olivia S. Jung, Carlos E. Astete, Myungwoong Kim, Jangwook P. Jung
Publikováno v:
ACS Applied Materials & Interfaces. 15:18639-18652